Search

everythinglearnresearchcommunity

for

Search:↓

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Some breast cancer chemotherapy can cause permanent hair loss.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

More research is needed to understand chemotherapy-induced hair loss and its phases.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Chemotherapy caused a woman's permanent hair loss and early menopause.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

A lotion with natural extracts significantly sped up hair growth in women with hair loss from chemotherapy.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.